Cargando…
218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia
BACKGROUND: Pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin and skin structure infection (ABSSSI) are the most common infections treated in the inpatient setting and often are associated with bacteremia. Though short courses of treatment are advocated for these infections in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809856/ http://dx.doi.org/10.1093/ofid/ofz360.293 |
_version_ | 1783462099445350400 |
---|---|
author | Hojat, Leila Bessesen, Mary T Reid, Margaret Knepper, Bryan C Miller, Matthew A Huang, Misha Fugit, Randolph V Shihadeh, Katherine C Jenkins, Timothy C |
author_facet | Hojat, Leila Bessesen, Mary T Reid, Margaret Knepper, Bryan C Miller, Matthew A Huang, Misha Fugit, Randolph V Shihadeh, Katherine C Jenkins, Timothy C |
author_sort | Hojat, Leila |
collection | PubMed |
description | BACKGROUND: Pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin and skin structure infection (ABSSSI) are the most common infections treated in the inpatient setting and often are associated with bacteremia. Though short courses of treatment are advocated for these infections in general, no established guidelines exist for cases involving bacteremia. We evaluated the clinical outcomes of patients receiving short (5–9 days) vs. long (10–15 days) duration of antibiotic treatment. METHODS: A retrospective study was conducted at 3 area hospitals comprising a university-based tertiary center, a public safety net hospital, and a Veterans’ Affairs hospital. We included hospitalized adult patients with transient bacteremia associated with uncomplicated cases of PNA, UTI, or ABSSSI. The primary outcome consisted of a composite of rehospitalization or resumption of antibiotic treatment attributed to the original infection or death due to any cause within 30 days of the antibiotic start date. Secondary outcomes included the individual composite components, Clostridioides difficile infection, and antibiotic-related adverse effects leading to change in antibiotic therapy. A propensity score weighted logistic regression model was used to mitigate factors which could bias a patient toward receiving a shorter or longer treatment duration. RESULTS: Of 411 patients included in the study, 123 (29.9%) received a short duration of therapy and 288 (70.1%) received a long duration of therapy. The median duration of treatment was 8 days in the short group and 13 days in the long group. In the propensity-weighted analysis, the probability of meeting the composite primary outcome was not statistically different between the short and long groups (Table 1). However, receiving a short course was associated with a higher probability of restarting antibiotics and Clostridioides difficile infection. CONCLUSION: Shorter vs. longer courses of antibiotic treatment for bacteremia associated with PNA, UTI, and ABSSSI were not significantly different in a composite of readmission, restart of antibiotics, and mortality; however, further study is needed to evaluate the safety and effectiveness of short-course therapy. [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6809856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68098562019-10-28 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia Hojat, Leila Bessesen, Mary T Reid, Margaret Knepper, Bryan C Miller, Matthew A Huang, Misha Fugit, Randolph V Shihadeh, Katherine C Jenkins, Timothy C Open Forum Infect Dis Abstracts BACKGROUND: Pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin and skin structure infection (ABSSSI) are the most common infections treated in the inpatient setting and often are associated with bacteremia. Though short courses of treatment are advocated for these infections in general, no established guidelines exist for cases involving bacteremia. We evaluated the clinical outcomes of patients receiving short (5–9 days) vs. long (10–15 days) duration of antibiotic treatment. METHODS: A retrospective study was conducted at 3 area hospitals comprising a university-based tertiary center, a public safety net hospital, and a Veterans’ Affairs hospital. We included hospitalized adult patients with transient bacteremia associated with uncomplicated cases of PNA, UTI, or ABSSSI. The primary outcome consisted of a composite of rehospitalization or resumption of antibiotic treatment attributed to the original infection or death due to any cause within 30 days of the antibiotic start date. Secondary outcomes included the individual composite components, Clostridioides difficile infection, and antibiotic-related adverse effects leading to change in antibiotic therapy. A propensity score weighted logistic regression model was used to mitigate factors which could bias a patient toward receiving a shorter or longer treatment duration. RESULTS: Of 411 patients included in the study, 123 (29.9%) received a short duration of therapy and 288 (70.1%) received a long duration of therapy. The median duration of treatment was 8 days in the short group and 13 days in the long group. In the propensity-weighted analysis, the probability of meeting the composite primary outcome was not statistically different between the short and long groups (Table 1). However, receiving a short course was associated with a higher probability of restarting antibiotics and Clostridioides difficile infection. CONCLUSION: Shorter vs. longer courses of antibiotic treatment for bacteremia associated with PNA, UTI, and ABSSSI were not significantly different in a composite of readmission, restart of antibiotics, and mortality; however, further study is needed to evaluate the safety and effectiveness of short-course therapy. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809856/ http://dx.doi.org/10.1093/ofid/ofz360.293 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Hojat, Leila Bessesen, Mary T Reid, Margaret Knepper, Bryan C Miller, Matthew A Huang, Misha Fugit, Randolph V Shihadeh, Katherine C Jenkins, Timothy C 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title | 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title_full | 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title_fullStr | 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title_full_unstemmed | 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title_short | 218. Evaluation of Clinical Outcomes with Shorter Vs. Longer Duration of Treatment for Common Inpatient Bacterial Infections Associated with Bacteremia |
title_sort | 218. evaluation of clinical outcomes with shorter vs. longer duration of treatment for common inpatient bacterial infections associated with bacteremia |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809856/ http://dx.doi.org/10.1093/ofid/ofz360.293 |
work_keys_str_mv | AT hojatleila 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT bessesenmaryt 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT reidmargaret 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT knepperbryanc 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT millermatthewa 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT huangmisha 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT fugitrandolphv 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT shihadehkatherinec 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia AT jenkinstimothyc 218evaluationofclinicaloutcomeswithshortervslongerdurationoftreatmentforcommoninpatientbacterialinfectionsassociatedwithbacteremia |